Facilitating pharma's future BioCentriq, New Jersey’s newest CDMO, is designed to help usher in the next era of cell and gene therapy By Karen Langhauser, Chief Content Director Feb 04, 2021 Launching a state-of-the-art facility focused on filling critical gaps in manufacturing cell and gene therapy — revolutionary yet complex treatments with the potential to change medicine — is no easy feat. It’s a given that it takes years of planning, millions in financial resources, a focused business model and ample technical and regulatory expertise.
Links to healthy food recipes and general health related resources and tips